I understand this and am not disagreeing with you. It is a good play as long as they have the funding on hand or in the works to do so (which I believe they have in the works). If they do not have cash, then these additional costs (while relatively inexpensive) will be funded with dilution and at the current share price that is not a good option unless it is to ink better terms in the very near future. Adding pipeline potential and value to CYDY is great as long as they can keep afloat until this value is realized.
I have confidence that the BOD and management know what they are doing. Again, I think this will play out well for us longs, but until a deal is finalized, cash is received or positive NASH results are known, it creates additional risk and little to no value. Not that I put much meaning on it at the moment, but today's action doesn't view this favorable.
(0)
(0)
CytoDyn Inc (CYDY) Stock Research Links
Please do your own due diligence. All my posts and comments are not to be considered investment advice.